| Revision as of 19:36, 28 December 2024 editSvampesky (talk | contribs)Extended confirmed users, IP block exemptions3,086 edits Ce on new article.← Previous edit | Revision as of 19:56, 28 December 2024 edit undoAnomieBOT (talk | contribs)Bots6,567,040 editsm Dating maintenance tags: {{One source}}Next edit → | ||
| Line 1: | Line 1: | ||
| {{One source}} | {{One source|date=December 2024}} | ||
| {{Short description|Laboratory test for bladder cancer}} | {{Short description|Laboratory test for bladder cancer}} | ||
| The '''bladder tumour antigen''' (BTA) test is used in the detection of ]. It works by detecting raised levels of complement factor H‐related protein (CFHrp), which is produced by cancer cells, in urine. The test can be qualitative, in which just the presence of the antigen is detected or quantitative, in which the ''amount'' of the antigen is measured. <ref name="pmid35950042">{{cite journal |vauthors=Soputro NA, Gracias DN, Dias BH, Nzenza T, O'Connell H, Sethi K |title=Utility of urinary biomarkers in primary haematuria: Systematic review and meta-analysis |journal=BJUI Compass |volume=3 |issue=5 |pages=334–343 |date=September 2022 |pmid=35950042 |pmc=9349596 |doi=10.1002/bco2.147 |url=}}</ref> | The '''bladder tumour antigen''' (BTA) test is used in the detection of ]. It works by detecting raised levels of complement factor H‐related protein (CFHrp), which is produced by cancer cells, in urine. The test can be qualitative, in which just the presence of the antigen is detected or quantitative, in which the ''amount'' of the antigen is measured. <ref name="pmid35950042">{{cite journal |vauthors=Soputro NA, Gracias DN, Dias BH, Nzenza T, O'Connell H, Sethi K |title=Utility of urinary biomarkers in primary haematuria: Systematic review and meta-analysis |journal=BJUI Compass |volume=3 |issue=5 |pages=334–343 |date=September 2022 |pmid=35950042 |pmc=9349596 |doi=10.1002/bco2.147 |url=}}</ref> | ||
Revision as of 19:56, 28 December 2024
 | This article relies largely or entirely on a single source. Please help improve this article by introducing citations to additional sources. Find sources: "Bladder tumor antigen" – news · newspapers · books · scholar · JSTOR (December 2024) |
The bladder tumour antigen (BTA) test is used in the detection of bladder cancer. It works by detecting raised levels of complement factor H‐related protein (CFHrp), which is produced by cancer cells, in urine. The test can be qualitative, in which just the presence of the antigen is detected or quantitative, in which the amount of the antigen is measured.
References
- Soputro NA, Gracias DN, Dias BH, Nzenza T, O'Connell H, Sethi K (September 2022). "Utility of urinary biomarkers in primary haematuria: Systematic review and meta-analysis". BJUI Compass. 3 (5): 334–343. doi:10.1002/bco2.147. PMC 9349596. PMID 35950042.